Icecure Medical Q4 EPS $(0.07), Inline, Sales $1.25M Beat $1.17M Estimate
Portfolio Pulse from Benzinga Newsdesk
Icecure Medical (NASDAQ:ICCM) reported Q4 earnings with EPS of $(0.07), meeting analyst estimates, and sales of $1.25M, exceeding the $1.17M estimate by 7.26%.
April 04, 2024 | 3:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Icecure Medical reported Q4 EPS of $(0.07), in line with estimates, and sales of $1.25M, surpassing the $1.17M estimate.
Meeting EPS estimates and exceeding sales forecasts typically indicates a positive performance, which can lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100